New

Meningococcal Vaccines Market

2021

Meningococcal Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Quadrivalent Vaccines, Bivalent Vaccines, Serogroup A, Serogroup B, Serogroup X); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

| Report Code: TIPRE00004064 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Meningococcal Vaccines Market 2028 By Type, Distribution Channel and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Meningococcal vaccines are utilized in the treatment and prevention of septicemia ,meningitis, pneumonia and meningococcemia. Meningitis is the inflammation of the membranes which also cover the brain and spinal cord. This type of inflammation generally occurs by infection of bacteria, viruses and by drugs. Earlier, there were no safety precautions in place to prevent meningitis. After infection was diagnosed, antibiotics and vitamin supplements were administered to treat the condition.

MARKET SCOPE



The "Global Meningococcal Vaccines Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the meningococcal vaccines market with detailed market segmentation by type and distribution channel. The report provides key statistics on the market status of the leading meningococcal vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on type the market is segmented as, quadrivalent vaccines, bivalent vaccines, serogroup A, serogroup B and serogroup X.
  • Based on distribution channel the market is segmented as, hospital pharmacies, retail pharmacies and online pharmacies.

MARKET DYNAMICS


Drivers:



  • Increasing prevalence of meningococcal infections across the globe is the key driving factor for the market growth.
  • Various government awareness program to spread awareness regarding vaccination to prevent consiquences of infections.
  • Increase R&D spending for development of meningococcal vaccines is also expected to spur market growth during the forecast period.

Restraints:



  • However, involvement of high cost for development of vaccines and stringent regulatory approval procedure are likely to impede market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The meningococcal vaccines market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the meningococcal vaccines market in these regions.

IMPACT OF COVID-19 ON MENINGOCOCCAL VACCINES MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the meningococcal vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from meningococcal vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for meningococcal vaccines in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the meningococcal vaccines market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  • Pfizer Inc.
  • Incepta Pharma
  • Novartis AG
  • Sanofi
  • Zhi Fei Biological
  • BIO-MED
  • Serum Institute of India Pvt. Ltd
  • GlaxoSmithKline plc
  • Merck Sharp and Dohme Corp
  • Bio-Manguinhos
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Meningococcal Vaccines Market - By Type
    1.3.2 Meningococcal Vaccines Market - By Distribution Channel
    1.3.3 Meningococcal Vaccines Market - By Region
    1.3.3.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. MENINGOCOCCAL VACCINES MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PORTER'S FIVE FORCES ANALYSIS
    4.2.1 Bargaining Power of Buyers
    4.2.1 Bargaining Power of Suppliers
    4.2.1 Threat of Substitute
    4.2.1 Threat of New Entrants
    4.2.1 Competitive Rivalry
    4.3. EXPERT OPINIONS

    5. MENINGOCOCCAL VACCINES MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. MENINGOCOCCAL VACCINES MARKET - GLOBAL MARKET ANALYSIS
    6.1. MENINGOCOCCAL VACCINES - GLOBAL MARKET OVERVIEW
    6.2. MENINGOCOCCAL VACCINES - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. MENINGOCOCCAL VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
    7.1. OVERVIEW
    7.2. TYPE MARKET FORECASTS AND ANALYSIS
    7.3. QUADRIVALENT VACCINES
    7.3.1. Overview
    7.3.2. Quadrivalent Vaccines Market Forecast and Analysis
    7.4. BIVALENT VACCINES
    7.4.1. Overview
    7.4.2. Bivalent Vaccines Market Forecast and Analysis
    7.5. SEROGROUP A
    7.5.1. Overview
    7.5.2. Serogroup A Market Forecast and Analysis
    7.6. SEROGROUP B
    7.6.1. Overview
    7.6.2. Serogroup B Market Forecast and Analysis
    7.7. SEROGROUP X
    7.7.1. Overview
    7.7.2. Serogroup X Market Forecast and Analysis
    8. MENINGOCOCCAL VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
    8.1. OVERVIEW
    8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
    8.3. HOSPITAL PHARMACIES
    8.3.1. Overview
    8.3.2. Hospital Pharmacies Market Forecast and Analysis
    8.4. RETAIL PHARMACIES
    8.4.1. Overview
    8.4.2. Retail Pharmacies Market Forecast and Analysis
    8.5. ONLINE PHARMACIES
    8.5.1. Overview
    8.5.2. Online Pharmacies Market Forecast and Analysis

    9. MENINGOCOCCAL VACCINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    9.1. NORTH AMERICA
    9.1.1 North America Meningococcal Vaccines Market Overview
    9.1.2 North America Meningococcal Vaccines Market Forecasts and Analysis
    9.1.3 North America Meningococcal Vaccines Market Forecasts and Analysis - By Type
    9.1.4 North America Meningococcal Vaccines Market Forecasts and Analysis - By Distribution Channel
    9.1.5 North America Meningococcal Vaccines Market Forecasts and Analysis - By Countries
    9.1.5.1 United States Meningococcal Vaccines Market
    9.1.5.1.1 United States Meningococcal Vaccines Market by Type
    9.1.5.1.2 United States Meningococcal Vaccines Market by Distribution Channel
    9.1.5.2 Canada Meningococcal Vaccines Market
    9.1.5.2.1 Canada Meningococcal Vaccines Market by Type
    9.1.5.2.2 Canada Meningococcal Vaccines Market by Distribution Channel
    9.1.5.3 Mexico Meningococcal Vaccines Market
    9.1.5.3.1 Mexico Meningococcal Vaccines Market by Type
    9.1.5.3.2 Mexico Meningococcal Vaccines Market by Distribution Channel
    9.2. EUROPE
    9.2.1 Europe Meningococcal Vaccines Market Overview
    9.2.2 Europe Meningococcal Vaccines Market Forecasts and Analysis
    9.2.3 Europe Meningococcal Vaccines Market Forecasts and Analysis - By Type
    9.2.4 Europe Meningococcal Vaccines Market Forecasts and Analysis - By Distribution Channel
    9.2.5 Europe Meningococcal Vaccines Market Forecasts and Analysis - By Countries
    9.2.5.1 Germany Meningococcal Vaccines Market
    9.2.5.1.1 Germany Meningococcal Vaccines Market by Type
    9.2.5.1.2 Germany Meningococcal Vaccines Market by Distribution Channel
    9.2.5.2 France Meningococcal Vaccines Market
    9.2.5.2.1 France Meningococcal Vaccines Market by Type
    9.2.5.2.2 France Meningococcal Vaccines Market by Distribution Channel
    9.2.5.3 Italy Meningococcal Vaccines Market
    9.2.5.3.1 Italy Meningococcal Vaccines Market by Type
    9.2.5.3.2 Italy Meningococcal Vaccines Market by Distribution Channel
    9.2.5.4 Spain Meningococcal Vaccines Market
    9.2.5.4.1 Spain Meningococcal Vaccines Market by Type
    9.2.5.4.2 Spain Meningococcal Vaccines Market by Distribution Channel
    9.2.5.5 United Kingdom Meningococcal Vaccines Market
    9.2.5.5.1 United Kingdom Meningococcal Vaccines Market by Type
    9.2.5.5.2 United Kingdom Meningococcal Vaccines Market by Distribution Channel
    9.2.5.6 Rest of Europe Meningococcal Vaccines Market
    9.2.5.6.1 Rest of Europe Meningococcal Vaccines Market by Type
    9.2.5.6.2 Rest of Europe Meningococcal Vaccines Market by Distribution Channel
    9.3. ASIA-PACIFIC
    9.3.1 Asia-Pacific Meningococcal Vaccines Market Overview
    9.3.2 Asia-Pacific Meningococcal Vaccines Market Forecasts and Analysis
    9.3.3 Asia-Pacific Meningococcal Vaccines Market Forecasts and Analysis - By Type
    9.3.4 Asia-Pacific Meningococcal Vaccines Market Forecasts and Analysis - By Distribution Channel
    9.3.5 Asia-Pacific Meningococcal Vaccines Market Forecasts and Analysis - By Countries
    9.3.5.1 Australia Meningococcal Vaccines Market
    9.3.5.1.1 Australia Meningococcal Vaccines Market by Type
    9.3.5.1.2 Australia Meningococcal Vaccines Market by Distribution Channel
    9.3.5.2 China Meningococcal Vaccines Market
    9.3.5.2.1 China Meningococcal Vaccines Market by Type
    9.3.5.2.2 China Meningococcal Vaccines Market by Distribution Channel
    9.3.5.3 India Meningococcal Vaccines Market
    9.3.5.3.1 India Meningococcal Vaccines Market by Type
    9.3.5.3.2 India Meningococcal Vaccines Market by Distribution Channel
    9.3.5.4 Japan Meningococcal Vaccines Market
    9.3.5.4.1 Japan Meningococcal Vaccines Market by Type
    9.3.5.4.2 Japan Meningococcal Vaccines Market by Distribution Channel
    9.3.5.5 South Korea Meningococcal Vaccines Market
    9.3.5.5.1 South Korea Meningococcal Vaccines Market by Type
    9.3.5.5.2 South Korea Meningococcal Vaccines Market by Distribution Channel
    9.3.5.6 Rest of Asia-Pacific Meningococcal Vaccines Market
    9.3.5.6.1 Rest of Asia-Pacific Meningococcal Vaccines Market by Type
    9.3.5.6.2 Rest of Asia-Pacific Meningococcal Vaccines Market by Distribution Channel
    9.4. MIDDLE EAST AND AFRICA
    9.4.1 Middle East and Africa Meningococcal Vaccines Market Overview
    9.4.2 Middle East and Africa Meningococcal Vaccines Market Forecasts and Analysis
    9.4.3 Middle East and Africa Meningococcal Vaccines Market Forecasts and Analysis - By Type
    9.4.4 Middle East and Africa Meningococcal Vaccines Market Forecasts and Analysis - By Distribution Channel
    9.4.5 Middle East and Africa Meningococcal Vaccines Market Forecasts and Analysis - By Countries
    9.4.5.1 South Africa Meningococcal Vaccines Market
    9.4.5.1.1 South Africa Meningococcal Vaccines Market by Type
    9.4.5.1.2 South Africa Meningococcal Vaccines Market by Distribution Channel
    9.4.5.2 Saudi Arabia Meningococcal Vaccines Market
    9.4.5.2.1 Saudi Arabia Meningococcal Vaccines Market by Type
    9.4.5.2.2 Saudi Arabia Meningococcal Vaccines Market by Distribution Channel
    9.4.5.3 U.A.E Meningococcal Vaccines Market
    9.4.5.3.1 U.A.E Meningococcal Vaccines Market by Type
    9.4.5.3.2 U.A.E Meningococcal Vaccines Market by Distribution Channel
    9.4.5.4 Rest of Middle East and Africa Meningococcal Vaccines Market
    9.4.5.4.1 Rest of Middle East and Africa Meningococcal Vaccines Market by Type
    9.4.5.4.2 Rest of Middle East and Africa Meningococcal Vaccines Market by Distribution Channel
    9.5. SOUTH AND CENTRAL AMERICA
    9.5.1 South and Central America Meningococcal Vaccines Market Overview
    9.5.2 South and Central America Meningococcal Vaccines Market Forecasts and Analysis
    9.5.3 South and Central America Meningococcal Vaccines Market Forecasts and Analysis - By Type
    9.5.4 South and Central America Meningococcal Vaccines Market Forecasts and Analysis - By Distribution Channel
    9.5.5 South and Central America Meningococcal Vaccines Market Forecasts and Analysis - By Countries
    9.5.5.1 Brazil Meningococcal Vaccines Market
    9.5.5.1.1 Brazil Meningococcal Vaccines Market by Type
    9.5.5.1.2 Brazil Meningococcal Vaccines Market by Distribution Channel
    9.5.5.2 Argentina Meningococcal Vaccines Market
    9.5.5.2.1 Argentina Meningococcal Vaccines Market by Type
    9.5.5.2.2 Argentina Meningococcal Vaccines Market by Distribution Channel
    9.5.5.3 Rest of South and Central America Meningococcal Vaccines Market
    9.5.5.3.1 Rest of South and Central America Meningococcal Vaccines Market by Type
    9.5.5.3.2 Rest of South and Central America Meningococcal Vaccines Market by Distribution Channel

    10. INDUSTRY LANDSCAPE
    10.1. MERGERS AND ACQUISITIONS
    10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    10.3. NEW PRODUCT LAUNCHES
    10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    11. MENINGOCOCCAL VACCINES MARKET, KEY COMPANY PROFILES
    11.1. PFIZER INC.
    11.1.1. Key Facts
    11.1.2. Business Description
    11.1.3. Products and Services
    11.1.4. Financial Overview
    11.1.5. SWOT Analysis
    11.1.6. Key Developments
    11.2. INCEPTA PHARMA
    11.2.1. Key Facts
    11.2.2. Business Description
    11.2.3. Products and Services
    11.2.4. Financial Overview
    11.2.5. SWOT Analysis
    11.2.6. Key Developments
    11.3. NOVARTIS AG
    11.3.1. Key Facts
    11.3.2. Business Description
    11.3.3. Products and Services
    11.3.4. Financial Overview
    11.3.5. SWOT Analysis
    11.3.6. Key Developments
    11.4. SANOFI
    11.4.1. Key Facts
    11.4.2. Business Description
    11.4.3. Products and Services
    11.4.4. Financial Overview
    11.4.5. SWOT Analysis
    11.4.6. Key Developments
    11.5. ZHI FEI BIOLOGICAL
    11.5.1. Key Facts
    11.5.2. Business Description
    11.5.3. Products and Services
    11.5.4. Financial Overview
    11.5.5. SWOT Analysis
    11.5.6. Key Developments
    11.6. BIO-MED
    11.6.1. Key Facts
    11.6.2. Business Description
    11.6.3. Products and Services
    11.6.4. Financial Overview
    11.6.5. SWOT Analysis
    11.6.6. Key Developments
    11.7. SERUM INSTITUTE OF INDIA PVT. LTD
    11.7.1. Key Facts
    11.7.2. Business Description
    11.7.3. Products and Services
    11.7.4. Financial Overview
    11.7.5. SWOT Analysis
    11.7.6. Key Developments
    11.8. GLAXOSMITHKLINE PLC
    11.8.1. Key Facts
    11.8.2. Business Description
    11.8.3. Products and Services
    11.8.4. Financial Overview
    11.8.5. SWOT Analysis
    11.8.6. Key Developments
    11.9. MERCK SHARP AND DOHME CORP
    11.9.1. Key Facts
    11.9.2. Business Description
    11.9.3. Products and Services
    11.9.4. Financial Overview
    11.9.5. SWOT Analysis
    11.9.6. Key Developments
    11.10. BIO-MANGUINHOS
    11.10.1. Key Facts
    11.10.2. Business Description
    11.10.3. Products and Services
    11.10.4. Financial Overview
    11.10.5. SWOT Analysis
    11.10.6. Key Developments

    12. APPENDIX
    12.1. ABOUT THE INSIGHT PARTNERS
    12.2. GLOSSARY OF TERMS
    The List of Companies

    1. Pfizer Inc.
    2. Incepta Pharma
    3. Novartis AG
    4. Sanofi
    5. Zhi Fei Biological
    6. BIO-MED
    7. Serum Institute of India Pvt. Ltd
    8. GlaxoSmithKline plc
    9. Merck Sharp and Dohme Corp
    10. Bio-Manguinhos
    TIPRE00004064
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking
    Request for Sample
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.